Monkeypox (Mpox) vaccines and their side effects: the other side of the coin.
作者信息
Sah Ranjit, Paul Diptanu, Mohanty Aroop, Shah Abhishek, Mohanasundaram Arun Sundar, Padhi Bijay K
机构信息
Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu.
Dr. D.Y. Patil Medical College, Hospital and Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra.
出版信息
Int J Surg. 2023 Feb 1;109(2):215-217. doi: 10.1097/JS9.0000000000000142.
Abstract
摘要
相似文献
1
Monkeypox (Mpox) vaccines and their side effects: the other side of the coin.猴痘疫苗及其副作用：硬币的另一面。
Int J Surg. 2023 Feb 1;109(2):215-217. doi: 10.1097/JS9.0000000000000142.
2
Safety and Efficacy of Repurposed Smallpox Vaccines Against Mpox: A Critical Review of ACAM2000, JYNNEOS, and LC16.用于抗猴痘的天花疫苗重新利用的安全性和有效性：对ACAM2000、JYNNEOS和LC16的批判性综述
J Epidemiol Glob Health. 2025 Jun 24;15(1):88. doi: 10.1007/s44197-025-00432-8.
3
Exploring monkeypox virus antibody levels: insights from human immunological research.探索猴痘病毒抗体水平：来自人体免疫学研究的见解
Virol J. 2025 May 31;22(1):175. doi: 10.1186/s12985-025-02748-0.
4
Effect of prior immunisation with smallpox vaccine for protection against human Mpox: A systematic review.天花疫苗预先免疫对预防人类猴痘的效果：一项系统评价。
Rev Med Virol. 2023 Jul;33(4):e2444. doi: 10.1002/rmv.2444. Epub 2023 Mar 30.
5
Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.在猴痘疫情期间，为年龄≥18岁有猴痘感染风险人群使用JYNNEOS（天花和猴痘活病毒非复制疫苗）：美国免疫实践咨询委员会的建议，2023年
MMWR Morb Mortal Wkly Rep. 2025 Jun 19;74(22):385-392. doi: 10.15585/mmwr.mm7422a3.
6
Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study.德国高危人群中MVA-BN痘苗接种预防猴痘的安全性和有效性（SEMVAc和TEMVAc）：一项前瞻性与回顾性队列联合研究
Lancet Infect Dis. 2025 Jul;25(7):775-787. doi: 10.1016/S1473-3099(25)00018-0. Epub 2025 Mar 18.
7
Correlation between microneutralization test and a multiplexed immunoassay for evaluation of monkeypox and vaccinia virus antibodies before and after smallpox vaccination.在天花疫苗接种前后，用于评估猴痘病毒和牛痘病毒抗体的微量中和试验与多重免疫测定之间的相关性。
Front Immunol. 2025 Jun 23;16:1585284. doi: 10.3389/fimmu.2025.1585284. eCollection 2025.
8
The impact of orthopoxvirus vaccination and Mpox infection on cross-protective immunity: a multicohort observational study.正痘病毒疫苗接种和猴痘感染对交叉保护性免疫的影响：一项多队列观察性研究。
Lancet Microbe. 2025 Apr 28:101098. doi: 10.1016/j.lanmic.2025.101098.
9
Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies.猴痘的预防与治疗：临床前研究的系统评价。
Viruses. 2022 Nov 11;14(11):2496. doi: 10.3390/v14112496.
10
Safety and Efficacy of Post-Eradication Smallpox Vaccine as an Mpox Vaccine: A Systematic Review with Meta-Analysis.根除天花疫苗作为猴痘疫苗的安全性和有效性：系统评价和荟萃分析。
Int J Environ Res Public Health. 2023 Feb 8;20(4):2963. doi: 10.3390/ijerph20042963.
引用本文的文献
1
Multivalent mpox protein nanoparticle vaccines confer cross-protection against orthopoxvirus infection.多价猴痘蛋白纳米颗粒疫苗对正痘病毒感染具有交叉保护作用。
PLoS Pathog. 2025 Aug 21;21(8):e1013389. doi: 10.1371/journal.ppat.1013389. eCollection 2025 Aug.
2
Development of a Broad-Spectrum Pan-Mpox Vaccine via Immunoinformatic Approaches.通过免疫信息学方法开发广谱泛痘疫苗。
Int J Mol Sci. 2025 Jul 25;26(15):7210. doi: 10.3390/ijms26157210.
3
Harnessing Artificial Intelligence and Innovative Vaccines for Mpox Diagnosis and Control: A Comprehensive Narrative Review.利用人工智能和创新疫苗进行猴痘诊断与控制：一项全面的叙述性综述
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251357701. doi: 10.1177/21501319251357701. Epub 2025 Jul 23.
4
Antigen recognition and immune response to monkeypox virus infection: implications for Mpox vaccine design - a narrative review.猴痘病毒感染的抗原识别与免疫反应：对猴痘疫苗设计的启示——一篇叙述性综述
Infez Med. 2025 Jun 1;33(2):151-162. doi: 10.53854/liim-3302-1. eCollection 2025.
5
Recent Advances in Mpox Epidemic: Global Features and Vaccine Prevention Research.猴痘疫情的最新进展：全球特征与疫苗预防研究
Vaccines (Basel). 2025 Apr 25;13(5):466. doi: 10.3390/vaccines13050466.
6
Is Southeast Asia and the Western Pacific ready for potential monkeypox virus outbreaks?东南亚和西太平洋地区是否已做好应对猴痘病毒潜在爆发的准备？
Lancet Reg Health West Pac. 2025 Mar 29;57:101526. doi: 10.1016/j.lanwpc.2025.101526. eCollection 2025 Apr.
7
Rational mpox vaccine design: immunogenicity and protective effect of individual and multicomponent proteins in mice.合理的猴痘疫苗设计：小鼠中单个和多组分蛋白的免疫原性及保护作用
Emerg Microbes Infect. 2025 Dec;14(1):2482702. doi: 10.1080/22221751.2025.2482702. Epub 2025 Mar 27.
8
Personalized immunization against Mpox Clades I and Ib: Strategies to combat the emerging epidemic.针对猴痘I和Ib分支的个性化免疫：应对新出现疫情的策略。
Infect Med (Beijing). 2025 Jan 15;4(1):100166. doi: 10.1016/j.imj.2025.100166. eCollection 2025 Mar.
9
Navigating monkeypox: identifying risks and implementing solutions.应对猴痘：识别风险并实施解决方案。
Open Vet J. 2024 Dec;14(12):3144-3163. doi: 10.5455/OVJ.2024.v14.i12.1. Epub 2024 Dec 31.
10
Mpox: Global epidemic situation and countermeasures.猴痘：全球疫情形势与应对措施。
Virulence. 2025 Dec;16(1):2457958. doi: 10.1080/21505594.2025.2457958. Epub 2025 Feb 8.
本文引用的文献
1
Cardiac events following JYNNEOS vaccination for prevention of Mpox.接种 JYNNEOS 疫苗预防猴痘后的心脏事件。
Vaccine. 2023 May 22;41(22):3410-3412. doi: 10.1016/j.vaccine.2023.04.052. Epub 2023 Apr 26.
2
FDA's authorized "JYNNEOS" vaccine for counteracting monkeypox global public health emergency; an update - Correspondence.美国食品药品监督管理局批准的用于应对猴痘全球公共卫生紧急情况的“JYNNEOS”疫苗；最新情况——通信
Int J Surg. 2022 Nov;107:106971. doi: 10.1016/j.ijsu.2022.106971. Epub 2022 Oct 29.
3
Monkeypox vaccines and vaccination strategies: Current knowledge and advances. An update - Correspondence.猴痘疫苗与接种策略：当前认知与进展。最新情况——通信
Int J Surg. 2022 Sep;105:106869. doi: 10.1016/j.ijsu.2022.106869. Epub 2022 Aug 30.
4
Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.使用 JYNNEOS（天花和猴痘疫苗，活病毒，非复制）对有职业性接触正痘病毒风险的人员进行暴露前疫苗接种：免疫实践咨询委员会的建议-美国，2022 年。
MMWR Morb Mortal Wkly Rep. 2022 Jun 3;71(22):734-742. doi: 10.15585/mmwr.mm7122e1.
5
Enhanced safety surveillance study of ACAM2000 smallpox vaccine among US military service members.美国军人中 ACAM2000 天花疫苗加强安全性监测研究。
Vaccine. 2021 Sep 15;39(39):5541-5547. doi: 10.1016/j.vaccine.2021.08.041. Epub 2021 Aug 26.
6
Vaccinating against monkeypox in the Democratic Republic of the Congo.在刚果民主共和国接种猴痘疫苗。
Antiviral Res. 2019 Feb;162:171-177. doi: 10.1016/j.antiviral.2018.11.004. Epub 2018 Nov 14.
7
Emergence of Monkeypox - West and Central Africa, 1970-2017.猴痘在西非和中非的出现，1970 - 2017年
MMWR Morb Mortal Wkly Rep. 2018 Mar 16;67(10):306-310. doi: 10.15585/mmwr.mm6710a5.
8
Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice.细胞培养制备的冻干减毒活天花疫苗“LC16 - 家蚕研”：符合良好临床实践的上市后安全性和有效性监测研究
Vaccine. 2015 Nov 9;33(45):6120-7. doi: 10.1016/j.vaccine.2015.09.067. Epub 2015 Oct 9.
9
Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects.冻干与液体形式的改良安卡拉痘苗（MVA）制剂以及在未接触过痘苗的健康受试者中皮下与皮内给药途径的比较。
Vaccine. 2015 Sep 22;33(39):5225-34. doi: 10.1016/j.vaccine.2015.06.075. Epub 2015 Jul 2.
10
Safety of attenuated smallpox vaccine LC16m8 in immunodeficient mice.减毒天花疫苗LC16m8在免疫缺陷小鼠中的安全性
Clin Vaccine Immunol. 2014 Sep;21(9):1261-6. doi: 10.1128/CVI.00199-14. Epub 2014 Jul 2.
Zotero 插件